Furthermore, NQO1 expression was also closely related to tumor progression, aggressiveness, resistance to chemotherapy, and poor patient outcomes (Hirose et al., 2021; Park et al., 2019; Xu et al., 2022). This evidence concerns the gene NQO1 and neoplasm.